Latest research findings by scientists at the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) could enable early screening of patients with hepatocellular carcinoma (HCC), a major form of liver cancer, for more aggressive treatment to improve survival rate. The researchers have also proposed a way to inactivate SALL4 - a stem cell gene - to kill HCC cells and block tumour formation.
↧